Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Global News Feed
Better Choice to Join Russell Microcap® Index
Posted: June 22, 2022 at 2:43 am
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today announced that the Company is anticipated to join the Russell Microcap® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2002.
Posted in Global News Feed
Comments Off on Better Choice to Join Russell Microcap® Index
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
Posted: June 22, 2022 at 2:43 am
First-of-a-kind Isotope Production System continues to progress towards commercial, industrial-scale production of medical isotopes for cancer therapeutics
Excerpt from:
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
Posted in Global News Feed
Comments Off on ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
Todos Medical Retains Moneta Advisory Partners as Strategic Advisors for National Exchange Listing and 3CL Pharma Spinoff
Posted: June 22, 2022 at 2:43 am
New York, NY, and Tel Aviv, ISRAEL, June 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has retained Moneta Advisory Partners (“Moneta”) to act as strategic advisors for the Company’s planned listing on a national exchange and the crowdfunding for the Company’s COVID and Long COVID theragnostics-focused joint venture 3CL Pharma. 3CL Pharma is the developer of the Phase 2/3-stage dual mechanism (3CL protease inhibitor and anti-cytokine) therapeutics candidate Tollovir™ for the treatment of hospitalized COVID-19 patients and the distributor of Tollovid®, the proprietary 3CL protease inhibitor immune support dietary supplement currently available on Amazon and www.MyTollovid.com.
Continue reading here:
Todos Medical Retains Moneta Advisory Partners as Strategic Advisors for National Exchange Listing and 3CL Pharma Spinoff
Posted in Global News Feed
Comments Off on Todos Medical Retains Moneta Advisory Partners as Strategic Advisors for National Exchange Listing and 3CL Pharma Spinoff
Moderated Webcast with BioPorto’s Management
Posted: June 22, 2022 at 2:43 am
COPENHAGEN, Denmark and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today provided details of a previously announced session with members of its management team.
More here:
Moderated Webcast with BioPorto’s Management
Posted in Global News Feed
Comments Off on Moderated Webcast with BioPorto’s Management
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
Posted: June 22, 2022 at 2:43 am
- Vote to approve share consolidation adjourned to July 6, 2022
Read more from the original source:
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
Posted in Global News Feed
Comments Off on Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Posted: June 22, 2022 at 2:43 am
Webcast presentation tomorrow, Wednesday, 22 June 2022, at 14.00 CET / 8 AM ET, www.glpg.com
Read more here:
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Posted in Global News Feed
Comments Off on Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod)…
Posted: June 22, 2022 at 2:43 am
Ad hoc announcement pursuant to Art. 53 LR
Here is the original post:
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod)...
Posted in Global News Feed
Comments Off on Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod)…
Paratek Pharmaceuticals’ NUZYRA® Receives FDA Fast Track Designation for the Treatment of Pulmonary Nontuberculous Mycobacterial (NTM) Disease…
Posted: June 22, 2022 at 2:43 am
-- Phase 2b Study in MAB Pulmonary Infections Ongoing and Enrolling as Planned
Read the original:
Paratek Pharmaceuticals’ NUZYRA® Receives FDA Fast Track Designation for the Treatment of Pulmonary Nontuberculous Mycobacterial (NTM) Disease...
Posted in Global News Feed
Comments Off on Paratek Pharmaceuticals’ NUZYRA® Receives FDA Fast Track Designation for the Treatment of Pulmonary Nontuberculous Mycobacterial (NTM) Disease…
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
Posted: June 22, 2022 at 2:43 am
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors.
Link:
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
Posted in Global News Feed
Comments Off on Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
Posted: June 22, 2022 at 2:43 am
TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. ("Dialco"), today announced the results of its Annual and Special Meeting of shareholders (the "Shareholders") held on June 20, 2022 (the "Meeting"). The Company is pleased to announce that all resolutions put forward in the Management Information Circular dated May 6, 2022 (the "Circular") to its Shareholders were approved.
See the original post:
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
Posted in Global News Feed
Comments Off on Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders